Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 91,534 shares at $16.29 ($1.5M) on 2024-09-20, disclosed to the SEC on 2024-09-23.
Scheduled sale ($1.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.29 | 42,099 | $686K | 45.9% |
| 2 | $16.29 | 42,099 | $686K | 45.9% |
| 3 | $16.78 | 3,668 | $62K | 4.1% |
| 4 | $16.78 | 3,668 | $62K | 4.1% |
| Total | $16.33 avg | 91,534 | $1.5M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |